GPX4 and pancreatic ductal adenocarcinoma: Studies have proved that HSPA5 can bind to GPX4 and inhibit GPX4 protein degradation, thereby inhibiting ferroptosis in pancreatic ductal adenocarcinoma (PDAC) cells and colorectal cancer (CRC) cells (34, 35).